Glycerol fructose injection is a hyperosmotic preparation that can reduce brain water content and intracranial pressure through hyperosmotic dehydration. This product has a slow onset and a longer duration of action in reducing intracranial pressure.

Glycerol fructose injection is a hyperosmotic preparation that can reduce brain water content and intracranial pressure through hyperosmotic dehydration. This product has a slow onset and a longer duration of action in reducing intracranial pressure.

This product belongs to the azole antifungal drug with a wide antifungal spectrum. It is effective against fungal infections in humans and various animals, including Candida infection, Cryptococcus neoformans infection, Malassezia furfur, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, F. fischeri, Cladosporium carinii, etc. The mechanism of action of this product is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane.

This product is a quinolone antibacterial drug, which has a strong antibacterial effect on Gram-negative bacteria (including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc.). It also has a moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase to achieve a bactericidal effect.